The global glucose monitoring devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and obesity in developing countries, which are driving the demand for these devices.
SelMonitoring Devices accounted for the largest share in the global glucose monitoring devices market in 2017, followed by Continuous Glucose Monitoring Devices. SelMonitoring Devices are used as an alternative to blood glucose testing strips and provide a more convenient way for patients with diabetes to monitor their blood sugar levels without having to prick their fingers or use lancets. SelMonitoring Devices are also used by people who have hypoglycemia unawareness or who have difficulty using traditional methods such as finger pricking or lancing due to physical limitations such as arthritis or nerve damage. Continuous Glucose Monitoring Devices provide continuous readings on blood sugar levels and can be used by people with type 1 diabetes who need insulin therapy, pregnant women with gestational diabetes, and those with type 2 diabetes who need insulin therapy but do not want it injected into their body through needles.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of diabetes is a major factor driving the growth of the glucose monitoring devices market.
- The increasing number of people suffering from diabetes is a major factor driving the growth of the glucose monitoring devices market.
- The rising awareness about diabetes and its complications among people is a major factor driving the growth of the glucose monitoring devices market.
- The growing number of diabetic patients in developing countries such as China, India, and Brazil are also factors that are expected to drive this market.
- Increasing government initiatives for prevention and management programs for diabetes are also factors that will drive this market.
Industry Growth Insights published a new data on “Glucose Monitoring Devices Market”. The research report is titled “Glucose Monitoring Devices Market research by Types (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Applications (Hospitals, Clinics, Diagnostic Centers), By Players/Companies Abbott, Roche, LifeScan, Bayer, B. Braun Melsungen AG, DexCom Inc., Medtronic, Nova Biomedical Corporation, Terumo Corporation, Johnson and Johnson, Omron, ARKRAY, Nipro Dagnostics, Hainice Medical, Infopia, SENS. Inc., AgaMatrix Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glucose Monitoring Devices Market Research Report
By Type
Self-Monitoring Devices, Continuous Glucose Monitoring Devices
By Application
Hospitals, Clinics, Diagnostic Centers
By Companies
Abbott, Roche, LifeScan, Bayer, B. Braun Melsungen AG, DexCom Inc., Medtronic, Nova Biomedical Corporation, Terumo Corporation, Johnson and Johnson, Omron, ARKRAY, Nipro Dagnostics, Hainice Medical, Infopia, SENS. Inc., AgaMatrix Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Glucose Monitoring Devices Market Report Segments:
The global Glucose Monitoring Devices market is segmented on the basis of:
Types
Self-Monitoring Devices, Continuous Glucose Monitoring Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- LifeScan
- Bayer
- B. Braun Melsungen AG
- DexCom Inc.
- Medtronic
- Nova Biomedical Corporation
- Terumo Corporation
- Johnson and Johnson
- Omron
- ARKRAY
- Nipro Dagnostics
- Hainice Medical
- Infopia
- SENS. Inc.
- AgaMatrix Inc.
Highlights of The Glucose Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Self-Monitoring Devices
- Continuous Glucose Monitoring Devices
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glucose Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A glucose monitoring device is a medical device that helps monitor blood sugar levels. Glucose monitoring devices can be worn on the body, in the mouth, or inserted into a vein.
Some of the key players operating in the glucose monitoring devices market are Abbott, Roche, LifeScan, Bayer, B. Braun Melsungen AG, DexCom Inc., Medtronic, Nova Biomedical Corporation, Terumo Corporation, Johnson and Johnson, Omron, ARKRAY, Nipro Dagnostics, Hainice Medical, Infopia, SENS. Inc., AgaMatrix Inc..
The glucose monitoring devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glucose Monitoring Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glucose Monitoring Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glucose Monitoring Devices Market - Supply Chain
4.5. Global Glucose Monitoring Devices Market Forecast
4.5.1. Glucose Monitoring Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glucose Monitoring Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glucose Monitoring Devices Market Absolute $ Opportunity
5. Global Glucose Monitoring Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glucose Monitoring Devices Market Size and Volume Forecast by Type
5.3.1. Self-Monitoring Devices
5.3.2. Continuous Glucose Monitoring Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glucose Monitoring Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glucose Monitoring Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glucose Monitoring Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glucose Monitoring Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glucose Monitoring Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glucose Monitoring Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glucose Monitoring Devices Demand Share Forecast, 2019-2026
9. North America Glucose Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glucose Monitoring Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glucose Monitoring Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Diagnostic Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glucose Monitoring Devices Market Size and Volume Forecast by Type
9.7.1. Self-Monitoring Devices
9.7.2. Continuous Glucose Monitoring Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glucose Monitoring Devices Demand Share Forecast, 2019-2026
10. Latin America Glucose Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glucose Monitoring Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glucose Monitoring Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glucose Monitoring Devices Market Size and Volume Forecast by Type
10.7.1. Self-Monitoring Devices
10.7.2. Continuous Glucose Monitoring Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glucose Monitoring Devices Demand Share Forecast, 2019-2026
11. Europe Glucose Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glucose Monitoring Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glucose Monitoring Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glucose Monitoring Devices Market Size and Volume Forecast by Type
11.7.1. Self-Monitoring Devices
11.7.2. Continuous Glucose Monitoring Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glucose Monitoring Devices Demand Share, 2019-2026
12. Asia Pacific Glucose Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glucose Monitoring Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glucose Monitoring Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glucose Monitoring Devices Market Size and Volume Forecast by Type
12.7.1. Self-Monitoring Devices
12.7.2. Continuous Glucose Monitoring Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glucose Monitoring Devices Demand Share, 2019-2026
13. Middle East & Africa Glucose Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glucose Monitoring Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glucose Monitoring Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glucose Monitoring Devices Market Size and Volume Forecast by Type
13.7.1. Self-Monitoring Devices
13.7.2. Continuous Glucose Monitoring Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glucose Monitoring Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glucose Monitoring Devices Market: Market Share Analysis
14.2. Glucose Monitoring Devices Distributors and Customers
14.3. Glucose Monitoring Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LifeScan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. B. Braun Melsungen AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. DexCom Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medtronic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nova Biomedical Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Terumo Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Johnson and Johnson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Omron
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. ARKRAY
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Nipro Dagnostics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Hainice Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Infopia
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. SENS. Inc.
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. AgaMatrix Inc.
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
